Med-X (MXRX) Gross Margin %: 4.12% (As of Dec. 2022)


What is Med-X Gross Margin %?

Med-X MXRX Gross Margin % is 4.12% as of Dec. 2022.

Gross Margin % is calculated as gross profit divided by its revenue. Med-X's Gross Profit for the six months ended in Dec. 2022 was $0.04 Mil. Med-X's Revenue for the six months ended in Dec. 2022 was $0.97 Mil. Therefore, Med-X's Gross Margin % for the quarter that ended in Dec. 2022 was 4.12%.


The historical rank and industry rank for Med-X's Gross Margin % or its related term are showing as below:


MXRX's Gross Margin % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 26.37
* Ranked among companies with meaningful Gross Margin % only.

Med-X had a gross margin of 4.12% for the quarter that ended in Dec. 2022 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Med-X was 0.00% per year.

Med-X  (NAS:MXRX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Med-X had a gross margin of 4.12% for the quarter that ended in Dec. 2022 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Med-X Gross Margin % Related Terms

Med-X Gross Margin % Historical Data

* Premium members only.

The historical data trend for Med-X's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med-X Gross Margin % Chart

Med-X Annual Data
Trend Dec20 Dec21 Dec22
Gross Margin %
15.76 7.43 15.22

Med-X Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22
Gross Margin % 0.00 30.08 -14.09 27.47 4.12

MXRX vs : Gross Margin % Comparison

For the Household & Personal Products subindustry, Med-X's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Med-X Gross Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Med-X's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Med-X's Gross Margin % falls into.


Med-X Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Med-X's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0.3 / 1.853
=(Revenue - Cost of Goods Sold) / Revenue
=(1.853 - 1.571) / 1.853
=15.22 %

Med-X's Gross Margin for the quarter that ended in Dec. 2022 is calculated as


Gross Margin % (Q: Dec. 2022 )=Gross Profit (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=0 / 0.972
=(Revenue - Cost of Goods Sold) / Revenue
=(0.972 - 0.932) / 0.972
=4.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 4.12% mean?
Med-X (MXRX) has a Gross Margin % of 4.12% as of Dec. 2022. Gross margin is the ratio of total gross profit to net sales. View historical data on Med-X and its competitors.
Is Med-X's Gross Margin % too high?
Med-X's current Gross Margin % is 4.12%. The Consumer Packaged Goods industry median Gross Margin % is 26.37. Med-X's value of 4.12% is 84.4% below this industry median.
How does Med-X's Gross Margin % compare to ?
Med-X's Gross Margin % of 4.12% can be compared against companies in the Consumer Packaged Goods industry. The industry median Gross Margin % is 26.37. Med-X's value of 4.12% is 84.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.37, based on 1,901 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med-X's current Gross Margin % of 4.12% is 84.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Med-X and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med-X's current Gross Margin % is 4.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current Gross Margin % of 4.12%. The current Gross Margin % is 4.12% and 84.4% below the Consumer Packaged Goods industry median of 26.37. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Med-X (MXRX), the current Gross Margin % is 4.12% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med-X Business Description

Comparable Companies
Address 8236 Remmet Avenue, Canoga Park, CA, USA, 91304
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.